Cite
HARVARD Citation
Yadav, G. et al. (2018). Dolutegravir, Second Generation Integrase Inhibitor: A New Hope for HIV Patient. European journal of molecular and clinical medicine. 5 (1), pp. 20-29. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Yadav, G. et al. (2018). Dolutegravir, Second Generation Integrase Inhibitor: A New Hope for HIV Patient. European journal of molecular and clinical medicine. 5 (1), pp. 20-29. [Online].